These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34795372)

  • 1. Factor H-related protein 1 (FHR-1) is associated with atherosclerotic cardiovascular disease.
    Irmscher S; Zipfel SLH; Halder LD; Ivanov L; Gonzalez-Delgado A; Waldeyer C; Seiffert M; Brunner FJ; von der Heide M; Löschmann I; Wulf S; Czamara D; Papac-Milicevic N; Strauß O; Lorkowski S; Reichenspurner H; Holers MV; Banda NK; Zeller T; Binder EB; Binder CJ; Wiech T; Zipfel PF; Skerka C
    Sci Rep; 2021 Nov; 11(1):22511. PubMed ID: 34795372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated factor H-related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy.
    Tortajada A; Gutiérrez E; Goicoechea de Jorge E; Anter J; Segarra A; Espinosa M; Blasco M; Roman E; Marco H; Quintana LF; Gutiérrez J; Pinto S; Lopez-Trascasa M; Praga M; Rodriguez de Córdoba S
    Kidney Int; 2017 Oct; 92(4):953-963. PubMed ID: 28637589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FHR-1 Binds to C-Reactive Protein and Enhances Rather than Inhibits Complement Activation.
    Csincsi ÁI; Szabó Z; Bánlaki Z; Uzonyi B; Cserhalmi M; Kárpáti É; Tortajada A; Caesar JJE; Prohászka Z; Jokiranta TS; Lea SM; Rodríguez de Córdoba S; Józsi M
    J Immunol; 2017 Jul; 199(1):292-303. PubMed ID: 28533443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the Factor H Family Proteins FHR-1 and FHR-5 With DNA and Dead Cells: Implications for the Regulation of Complement Activation and Opsonization.
    Kárpáti É; Papp A; Schneider AE; Hajnal D; Cserhalmi M; Csincsi ÁI; Uzonyi B; Józsi M
    Front Immunol; 2020; 11():1297. PubMed ID: 32765490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation.
    Tortajada A; Yébenes H; Abarrategui-Garrido C; Anter J; García-Fernández JM; Martínez-Barricarte R; Alba-Domínguez M; Malik TH; Bedoya R; Cabrera Pérez R; López Trascasa M; Pickering MC; Harris CL; Sánchez-Corral P; Llorca O; Rodríguez de Córdoba S
    J Clin Invest; 2013 Jun; 123(6):2434-46. PubMed ID: 23728178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein.
    McRae JL; Duthy TG; Griggs KM; Ormsby RJ; Cowan PJ; Cromer BA; McKinstry WJ; Parker MW; Murphy BF; Gordon DL
    J Immunol; 2005 May; 174(10):6250-6. PubMed ID: 15879123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered Peripheral Blood Leucocyte Phenotype and Responses in Healthy Individuals with Homozygous Deletion of FHR1 and FHR3 Genes.
    Bhasym A; Gurjar BS; Prabhu S; Puraswani M; Khandelwal P; Saini H; Saini S; Chatterjee P; Bal V; George A; Coshic P; Patidar G; Hari P; Sinha A; Bagga A; Rath S; Guchhait P
    J Clin Immunol; 2019 Apr; 39(3):336-345. PubMed ID: 30945073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy.
    Medjeral-Thomas NR; Lomax-Browne HJ; Beckwith H; Willicombe M; McLean AG; Brookes P; Pusey CD; Falchi M; Cook HT; Pickering MC
    Kidney Int; 2017 Oct; 92(4):942-952. PubMed ID: 28673452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of Shiga toxin 2 with complement regulators of the factor H protein family.
    Poolpol K; Orth-Höller D; Speth C; Zipfel PF; Skerka C; de Córdoba SR; Brockmeyer J; Bielaszewska M; Würzner R
    Mol Immunol; 2014 Mar; 58(1):77-84. PubMed ID: 24317278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement Factor H Family Proteins Modulate Monocyte and Neutrophil Granulocyte Functions.
    Kárpáti É; Kremlitzka M; Sándor N; Hajnal D; Schneider AE; Józsi M
    Front Immunol; 2021; 12():660852. PubMed ID: 34671340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome.
    Bernabéu-Herrero ME; Jiménez-Alcázar M; Anter J; Pinto S; Sánchez Chinchilla D; Garrido S; López-Trascasa M; Rodríguez de Córdoba S; Sánchez-Corral P
    Mol Immunol; 2015 Oct; 67(2 Pt B):276-86. PubMed ID: 26163426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Murine Factor H-Related Protein FHR-B Promotes Complement Activation.
    Cserhalmi M; Csincsi ÁI; Mezei Z; Kopp A; Hebecker M; Uzonyi B; Józsi M
    Front Immunol; 2017; 8():1145. PubMed ID: 28974948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement Factor H-Related 3 Enhanced Inflammation and Complement Activation in Human RPE Cells.
    Schäfer N; Rasras A; Ormenisan DM; Amslinger S; Enzmann V; Jägle H; Pauly D
    Front Immunol; 2021; 12():769242. PubMed ID: 34819935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulation of Factor H by Factor H-Related Protein 1 Depends on Sialylation of Host Surfaces.
    Dopler A; Stibitzky S; Hevey R; Mannes M; Guariento M; Höchsmann B; Schrezenmeier H; Ricklin D; Schmidt CQ
    Front Immunol; 2021; 12():615748. PubMed ID: 33732239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor H-related protein 1: a complement regulatory protein and guardian of necrotic-type surfaces.
    Skerka C; Pradel G; Halder LD; Zipfel PF; Zipfel SLH; Strauß O
    Br J Pharmacol; 2021 Jul; 178(14):2823-2831. PubMed ID: 33085794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage mediated protein hydroperoxide formation and lipid oxidation in low density lipoprotein are inhibited by the inflammation marker 7,8-dihydroneopterin.
    Firth CA; Crone EM; Flavall EA; Roake JA; Gieseg SP
    Biochim Biophys Acta; 2008 Jun; 1783(6):1095-101. PubMed ID: 18342632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome.
    Zipfel PF; Edey M; Heinen S; Józsi M; Richter H; Misselwitz J; Hoppe B; Routledge D; Strain L; Hughes AE; Goodship JA; Licht C; Goodship TH; Skerka C
    PLoS Genet; 2007 Mar; 3(3):e41. PubMed ID: 17367211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.
    Koenig W
    Int J Cardiol; 2013 Oct; 168(6):5126-34. PubMed ID: 23978367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
    Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
    Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of a novel rat factor H-related protein that is up-regulated in glomeruli under complement attack.
    Ren G; Doshi M; Hack BK; Alexander JJ; Quigg RJ
    J Biol Chem; 2002 Dec; 277(50):48351-8. PubMed ID: 12374811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.